Home » DexCom Increases IPO Pricing
DexCom Increases IPO Pricing
Venture-backed glucose monitoring systems maker DexCom has bumped up the value of its initial public offering (IPO) by 8 percent to $75.7 million. The San Diego, Calif.-based company set the terms of the 4.7 million share offering at $12 to $14 an issue. On Feb. 1, DexCom estimated the IPO's value at $70 million.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May